Aspirin does not prevent recurrence after treatment for colorectal cancer liver metastases
November 02, 2026
November 02, 2026
OSLO, Norway, Nov. 2 -- The University of Oslo issued the following news:
* * *
Aspirin does not prevent recurrence after treatment for colorectal cancer liver metastases
*
Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world.
Approximately 30 per cent of patients with colorectal cancer develop liver metastases during the course of their disease. Once the dise . . .
* * *
Aspirin does not prevent recurrence after treatment for colorectal cancer liver metastases
*
Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world.
Approximately 30 per cent of patients with colorectal cancer develop liver metastases during the course of their disease. Once the dise . . .
